Location History:
- South Windham, CT (US) (1977)
- Swindham, CT (US) (1981)
Company Filing History:
Years Active: 1977-1981
Title: Steven J Gould: Innovator in Immunoassay Reagents
Introduction
Steven J Gould is a notable inventor based in South Windham, CT (US). He has made significant contributions to the field of immunoassay reagents, particularly in the detection of benzodiazepines. With a total of 2 patents, his work has advanced the capabilities of immunoassays in medical diagnostics.
Latest Patents
Gould's latest patents focus on oxazepam derivatives for immunoassay reagents. These compounds are designed for use in the preparation of reagents that can detect benzodiazepines, especially their urinary metabolites. The innovative compounds are non-oxo-carbonyl derivatives conjugated to the 3-position of the benzodiazepine. They are further conjugated to antigenic polypeptides, facilitating the formation of antibodies for use in immunoassays. The antibodies produced are effective in detecting the ingestion of a wide variety of benzodiazepine drugs, as evidenced by positive results in patient urine samples.
Career Highlights
Gould is associated with Syva Company, where he has contributed to the development of advanced immunoassay technologies. His expertise in the field has positioned him as a key player in the innovation of diagnostic reagents.
Collaborations
One of his notable collaborators is Richard S Schneider, with whom he has worked on various projects related to immunoassay development.
Conclusion
Steven J Gould's contributions to the field of immunoassay reagents have made a significant impact on medical diagnostics. His innovative work continues to enhance the detection of benzodiazepines, showcasing the importance of his inventions in healthcare.